What Happened?
Shares of medical device company ResMed (NYSE: RMD) fell 2.6% in the afternoon session after its Chairman and CEO, Michael J. Farrell, sold shares worth $1.25 million.
The transaction involved the sale of 4,991 shares at a weighted average price of $251.03. While the sale was conducted under a pre-arranged trading plan established in a previous year, significant insider selling can sometimes concern investors about a company's future prospects. Adding to the pressure, analysts at Baird also adjusted their price target on ResMed's stock downward to $272 from a previous target of $281, though they maintained a Neutral rating on the shares.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy ResMed? Access our full analysis report here, it’s free.
What Is The Market Telling Us
ResMed’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 4 months ago when the stock gained 3.6% on the news that comments from a key Federal Reserve official bolstered hopes for an interest rate cut.
New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
ResMed is down 2.1% since the beginning of the year, and at $239.72 per share, it is trading 18.4% below its 52-week high of $293.73 from August 2025. Investors who bought $1,000 worth of ResMed’s shares 5 years ago would now be looking at an investment worth $1,284.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
